Currently, Health Catalyst Inc [HCAT] is trading at $4.43, down -2.64%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The HCAT shares have gain 0.91% over the last week, with a monthly amount drifted -21.17%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Health Catalyst Inc [NASDAQ: HCAT] stock has seen the most recent analyst activity on January 08, 2025, when KeyBanc Capital Markets upgraded its rating to a Overweight but kept the price target unchanged to $9 for it. Previously, KeyBanc Capital Markets downgraded its rating to Sector Weight on April 10, 2024. On January 03, 2024, upgrade upgraded it’s rating to Outperform but maintained its price target of $11 on the stock. Barclays started tracking the stock assigning a Overweight rating and suggested a price target of $14 on January 03, 2024. JP Morgan upgraded its rating to a Overweight and reduced its price target to $11 on December 13, 2023. Piper Sandler upgraded its rating to Overweight for this stock on November 13, 2023, and downed its price target to $11. In a note dated August 01, 2023, Cantor Fitzgerald initiated an Overweight rating and provided a target price of $16 on this stock.
This stock has fluctuated between a low of $3.76 and a high of $9.24 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $7 within the next 12 months. Health Catalyst Inc [NASDAQ: HCAT] shares were valued at $4.43 at the most recent close of the market. An investor can expect a potential return of 58.01% based on the average HCAT price forecast.
Analyzing the HCAT fundamentals
Trailing Twelve Months sales for Health Catalyst Inc [NASDAQ:HCAT] were 306.58M which represents 6.02% growth. Gross Profit Margin for this corporation currently stands at 0.39% with Operating Profit Margin at -0.2%, Pretax Profit Margin comes in at -0.23%, and Net Profit Margin reading is -0.23%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.19 and Total Capital is -0.11. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.69.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.30 points at the first support level, and at 4.17 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.64, and for the 2nd resistance point, it is at 4.85.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Health Catalyst Inc [NASDAQ:HCAT] is 1.42. Further, the Quick Ratio stands at 1.42, while the Cash Ratio is 0.77. Considering the valuation of this stock, the price to sales ratio is 1.01, the price to book ratio is 0.78.
Transactions by insiders
Recent insider trading involved BENJAMIN LANDRY, Officer, that happened on Mar 06 ’25 when 13827.0 shares were purchased. Officer, DANIEL LESUEUR completed a deal on Mar 05 ’25 to buy 16902.0 shares. Meanwhile, Officer Daniel Burton bought 33677.0 shares on Mar 03 ’25.
